Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Emergent Biosolutions Inc. (EBS) had Debt to Equity Ratio of 1.14 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$231.10M |
|
$51.20M |
|
$85.90M |
|
$145.20M |
|
$154.60M |
|
$76.50M |
|
$-18.90M |
|
$57.60M |
|
$57.60M |
|
$51.20M |
|
$51.20M |
|
$51.20M |
|
$51.20M |
|
$76.50M |
|
$102.40M |
|
53.20M |
|
56.50M |
|
$0.96 |
|
$0.91 |
|
| Balance Sheet Financials | |
$786.90M |
|
$209.80M |
|
$674.10M |
|
$1.46B |
|
$136.50M |
|
$663.10M |
|
$742.00M |
|
$878.50M |
|
$582.50M |
|
$129.80M |
|
$582.50M |
|
52.70M |
|
| Cash Flow Statement Financials | |
$92.90M |
|
$73.30M |
|
$-22.70M |
|
$105.60M |
|
$249.20M |
|
$143.60M |
|
$10.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.76 |
|
-- |
|
-- |
|
0.53 |
|
|
Debt to Equity Ratio |
1.14 |
62.83% |
|
33.10% |
|
33.10% |
|
-- |
|
24.92% |
|
22.15% |
|
$121.20M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.24 |
|
1.55 |
|
58.22 |
|
8.79% |
|
39.45% |
|
3.50% |
|
4.11% |
|
$11.05 |
|
$2.15 |
|
$1.64 |
|